The latest announcement is out from Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ). Tribeca Global Natural Resources Ltd. announced the ...
Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ) just unveiled an update. Tribeca Global Natural Resources Ltd. has announced an update ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies ...
Keros Therapeutics, Inc. ('Keros” or the 'Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...
Gyre Therapeutics (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today ...
Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture CapitalPlans to Commence Tender Offer to Repurchase up ...
A recent study published in Life Metabolism by researchers from the Affiliated Hospital of Nantong University has identified ...
The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback